Maria Frantzi

12PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 09, 2025
Novel Strategy for Acquiring Metabolically-Tagged Nascent Extracellular Vesicles: Implications for Identifying Surface Protein Markers of Extracellular Vesicles From Neuroblastoma Cells Cultured With Native Serum.

Hugo P Markus, Edwin de Jong, Manousos Makridakis

|Aug 14, 2025
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology.

Yasra Fatima, Kirubel Nigusu Jobre, Enrique Gomez-Gomez

|May 12, 2025
Repurposing Amiodarone for Bladder Cancer Treatment.

Francisco J Roa, Maria Roubelakis, Konstantinos Paschidis

|Feb 25, 2023
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.

Maria Frantzi, Zoran Culig, Isabel Heidegger

|Oct 03, 2022
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.

Lourdes Mengual, Maria Frantzi, Marika Mokou

|May 28, 2022
Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature.

Rafael Stroggilos, Maria Frantzi, Jerome Zoidakis

Pageof 2

Frequent Collaborators

5 joint publications

Marika Mokou

5 joint publications

Antonia Vlahou

4 joint publications

Manousos Makridakis

4 joint publications

Harald Mischak